Botanical species · safety record

Tanacetum cinerariifolium

The EFSA Compendium of Botanicals holds 24 constituent measurements and 2 adverse-effect records for Tanacetum cinerariifolium. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Tanacetum cinerariifolium (Trevir.) Sch.Bip.

24Constituent measurements

2Safety records

6Cited sources

0Licensed products (Canada)

Also recorded as

Chrysanthemum cinerariifolium (Trevir). Vis.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Pyrethrins	Flower	Solvent extraction	≥ 2.12 Percent	HPLC-DAD	Resolve DOI
Pyrethrins	Flower	—	≥ 1 Percent	—	Resolve DOI
Pyrethrins	Flower	—	≤ 2 Percent	—	Resolve DOI
Pyrethrins	Flower	Solvent extraction	≤ 2.69 Percent	HPLC-DAD	Resolve DOI
Pyrethrins	Leaves	—	0.1 Percent	—	Resolve DOI
Thiophene	Roots and other underground parts	Solvent extraction	22 Microgram/gram	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
Thiophene	Stem / stalk	Solvent extraction	17 Microgram/gram	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
Thiophene	Flower	Solvent extraction	56 Microgram/gram	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
Thiophene	Leaves	Solvent extraction	23 Microgram/gram	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
Cinerin i	Flower	Solvent extraction	≥ 0.6 Milligram/gram	HPLC-DAD	No resolvable identifier
Cinerin i	Flower	Solvent extraction	≤ 1.25 Milligram/gram	HPLC-DAD	No resolvable identifier
Cinerin ii	Flower	Solvent extraction	≥ 0.52 Milligram/gram	HPLC-DAD	No resolvable identifier
Cinerin ii	Flower	Solvent extraction	≤ 0.57 Milligram/gram	HPLC-DAD	No resolvable identifier
Jasmolin i	Flower	Solvent extraction	≥ 0.23 Milligram/gram	HPLC-DAD	No resolvable identifier
Jasmolin i	Flower	Solvent extraction	≤ 0.36 Milligram/gram	HPLC-DAD	No resolvable identifier
Jasmolin ii	Flower	Solvent extraction	≥ 0.16 Milligram/gram	HPLC-DAD	No resolvable identifier
Jasmolin ii	Flower	Solvent extraction	≤ 0.19 Milligram/gram	HPLC-DAD	No resolvable identifier
Pyrethrin i	Flower	Solvent extraction	≥ 4.53 Milligram/gram	HPLC-DAD	No resolvable identifier
Pyrethrin i	Flower	Solvent extraction	≤ 7.42 Milligram/gram	HPLC-DAD	No resolvable identifier
Pyrethrin ii	Flower	Solvent extraction	≥ 2.25 Milligram/gram	HPLC-DAD	No resolvable identifier
Pyrethrin ii	Flower	Solvent extraction	≤ 4.31 Milligram/gram	HPLC-DAD	No resolvable identifier
Pyrethrins	Flower	Solvent extraction	≤ 11.96 Milligram/gram	HPLC-DAD	No resolvable identifier
Pyrethrins	Flower	Solvent extraction	0.82 Milligram/100 gram	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Pyrethrins	Flower	Solvent extraction	≥ 10.45 Milligram/gram	HPLC-DAD	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Reproductive	Uterus	Flower	—	Rat (as animal)	Reproduction toxicity	No resolvable identifier
Teratogenic	Muscle, skeletal	—	—	Rat (as animal)	Reproduction toxicity	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

TOSI, B., BONORA, A., DALLOLIO, G., BRUNI, A. SCREENING FOR TOXIC THIOPHENE COMPOUNDS FROM CRUDE DRUGS OF THE FAMILY COMPOSITAE USED IN NORTHERN ITALY . Phytotherapy research, 1991, vol. 5, no. 2, p. 59-62. DOI
KHERA, KS., WHALEN, C., ANGERS, G. TERATOGENICITY STUDY ON PYRETHRUM AND ROTENONE (NATURAL ORIGIN) AND RONNEL IN PREGNANT RATS . Journal of toxicology and environmental health, 1982, vol. 10, no. 1, p. 111-119.
Babic, S., Grdisa, M., Perisa, M., Asperger, D., Satovic, Z., Kastelan-Macan, M. Ultrasound-assisted extraction of pyrethrins from pyrethrum flowers. Agrochimica, 2012, vol. 56, no. 4-5, p. 193-206.
Morris, SE., Davies, NW., Brown, PH., Groom, T. Effect of drying conditions on pyrethrins content. Industrial crops and products, 2006, vol. 23, no. 1, p. 9-14. DOI
Stanciu, Gabriela., Lupsor, Simona., Sirbu, Rodica. QUANITITATIVE ANALYSIS OF PYRETHRINS FROM CHRYSANTHEMUM CINERARIIAEFOLIUM AND CHRYSANTHEMUM LEUCANTEUM PETALS . Journal of science and arts, 2017, no. 1, p. 141-146.
Yang, Ting., Stoopen, Geert., Wiegers, Gerrie., Mao, Jing., Wang, Caiyun., Dicke, Marcel., Jongsma, Maarten A. Pyrethrins Protect Pyrethrum Leaves Against Attack by Western Flower Thrips, Frankliniella occidentalis . Journal of chemical ecology, 2012, vol. 38, no. 4, p. 370-377. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature